Ignite Creation Date:
2024-05-06 @ 3:27 AM
Last Modification Date:
2024-10-26 @ 11:34 AM
Study NCT ID:
NCT02293395
Status:
COMPLETED
Last Update Posted:
2017-12-26
First Post:
2014-11-13
Brief Title:
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Sponsor:
Janssen Research Development LLC
Organization:
Janssen Research Development LLC
Organization Data
Organization:
Janssen Research Development LLC
Class:
INDUSTRY
Study ID:
CR106261
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Janssen Research Development LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bayer | INDUSTRY |
| Duke Clinical Research Institute | OTHER |
| Harvard Medical School HMS and HSDM | OTHER |